Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,745 | 34,117 | 21,084 | 14,250 | 13,715 |
| Marketable Securities | 13,262 | 16,096 | 16,492 | 25,516 | 20,251 |
| Receivables | 78,076 | 84,128 | 70,287 | 62,025 | 75,253 |
| Income taxes - deferred | 7,394 | 6,893 | 8,176 | 6,917 | 7,298 |
| Other current assets | 18,665 | 17,835 | 21,201 | 22,247 | 20,461 |
| TOTAL | $167,142 | $159,069 | $137,240 | $130,955 | $136,978 |
| Non-Current Assets | |||||
| PPE Net | 38,294 | 38,635 | 37,202 | 36,563 | 36,026 |
| Investments And Advances | 24,175 | 24,534 | 19,196 | 23,400 | 24,410 |
| Intangibles | 77,591 | 76,712 | 75,636 | 76,291 | 72,347 |
| Other Non-Current Assets | 33,432 | 34,074 | 36,053 | 34,409 | 28,423 |
| TOTAL | $173,492 | $173,955 | $168,087 | $170,663 | $161,206 |
| Total Assets | $340,634 | $333,024 | $305,327 | $301,618 | $298,184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,992 | 6,212 | 8,091 | 7,470 | 4,980 |
| Accrued Expenses | 35,089 | 43,505 | 35,833 | 39,022 | 33,711 |
| TOTAL | $149,233 | $156,671 | $138,228 | $137,725 | $132,206 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 108,152 | 106,954 | 94,304 | 91,233 | 93,515 |
| Other Non-Current Liabilities | 8,866 | 3,531 | 6,415 | 4,310 | 4,398 |
| TOTAL | $16,975 | $16,684 | $14,772 | $13,349 | $15,240 |
| Total Liabilities | $166,208 | $173,355 | $153,000 | $151,074 | $147,446 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,867 | 29,565 | 29,521 | 29,518 | 29,753 |
| Common Shares | 199 | 299 | 199 | 199 | 197 |
| Retained earnings | 150,224 | 143,175 | 132,815 | 126,318 | 120,545 |
| Other shareholders' equity | -1,457 | -1,199 | -972 | -1,475 | -1,445 |
| TOTAL | $174,426 | $159,669 | $152,327 | $150,544 | $150,738 |
| Total Liabilities And Equity | $340,634 | $333,024 | $305,327 | $301,618 | $298,184 |